BPC-157 (5mg)
Body Protection Compound-157 is a synthetic 15-amino acid pentadecapeptide sequence verified at ≥99.6% purity via analytical RP-HPLC and ESI mass spectrometry. Provided as a lyophilized powder in vacuum-sealed nitrogen-flushed vials.
Precision-synthesized peptide compounds formulated for maximum bioactivity. Every batch is manufactured under automated solid-phase synthesis and independently verified by reverse-phase HPLC and mass spectrometry.
Try another keyword or reset the filter.
Body Protection Compound-157 is a synthetic 15-amino acid pentadecapeptide sequence verified at ≥99.6% purity via analytical RP-HPLC and ESI mass spectrometry. Provided as a lyophilized powder in vacuum-sealed nitrogen-flushed vials.
Synthetic 43-amino acid derivative corresponding to the active actin-binding domain of Thymosin Beta-4. Certified ≥99.4% purity via analytical chromatography and mass spectrometry. Supplied lyophilized in sealed sterile glass vials.
Peptides are short chains of amino acid residues linked by peptide bonds. They function as targeted biological signaling molecules that direct cellular activity with high receptor specificity.
Unlike broad-spectrum compounds or traditional oral supplements that require liver first-pass metabolism, peptides bind selectively to defined cell surface receptors. This initiates precise intracellular signaling cascades—such as angiogenic tissue repair, actin filament stabilization, or incretin receptor activation.
During peptide synthesis, incomplete coupling can create truncation isomers and deletion sequences. These impure fragments can occupy receptor sites without activating the intended biological cascade. Praxar utilizes preparative Reverse-Phase HPLC to isolate the target peak, certifying each lot above 99.0% chemical purity.
In liquid aqueous solution, peptides are susceptible to hydrolytic cleavage and deamidation over time. To ensure maximum stability, our formulations are freeze-dried (lyophilized) into solid cakes under an inert nitrogen vacuum, protecting tertiary structure until reconstitution.
| Test Parameter | Analytical Methodology | Specification | Compliance |
|---|---|---|---|
| Chemical Purity | RP-HPLC (C18 Column, 214nm detection) | ≥ 99.0% Area | Pass (Individual COA) |
| Molecular Mass Verification | Electrospray Ionization Mass Spectrometry (ESI-MS) | ± 1.0 Da of Theoretical Mass | Pass (Verified Sequence) |
| Physical Form | Visual Inspection | Sterile Lyophilized Cake / Powder | Pass (Nitrogen Sealed) |
| Storage & Transit | Thermal Monitoring | -20°C Cold-Chain Packaging | Pass (Temperature Controlled) |
All Praxar formulations are certified to exceed 99.0% chemical purity, verified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS). Each order includes an individual batch Certificate of Analysis (COA).
Lyophilized peptide vials should be maintained frozen between -20°C and 4°C protected from direct sunlight. They are vacuum sealed under an inert nitrogen atmosphere to prevent oxidation and hydrolytic degradation.
Peptides should be reconstituted using sterile bacteriostatic water introduced slowly down the inner glass wall of the vial, followed by gentle swirling without shaking. Once reconstituted into solution, store refrigerated between 2°C and 8°C.
Cold-Chain Monitored Packaging
Select research peptides from our catalog with certified HPLC verification.
← Browse Catalog